Research News
Members of the GW Cancer Center recently published several journal articles and patient-focused pieces highlighting the Center’s work in patient navigation and survivorship.
For the first time, researchers at the GW School of Medicine and Health Sciences have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which...
Pedro A. Jose, MD, PhD, professor of medicine, received special recognition for his research contributions from Filipino President Rodrigo Duterte.
Researchers at the GW School of Medicine and Health Sciences will look for unknown genes associated with branchiootorenal spectrum disorders.
A team from GW led by Adam Friedman, MD, reviewed 35 studies on treatments for prurigo nodularis.
Researchers at SMHS found dermatologists are interested in learning more about and recommending therapeutic cannabinoids to patients.
Colin Young, PhD, received $2.4 million for his research on non-alcoholic fatty liver disease
Researchers from the GW Cancer Center published in JAMA Dermatology on the efficacy of preventative strategies for adverse effects of taxane-based chemotherapy.
The GW School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of a HIV vaccine candidate.
GW and the FDA published an update to the BioCompute Object Specification Project, which provides much-needed standards for communicating high-throughput sequencing computations and data analysis, known as BioCompute Objects.
